Man Group PLC Amicus Therapeutics, Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 736,328 shares of FOLD stock, worth $7.29 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

736,328

Holding current value

$7.29 Million

% of portfolio

0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $7.03 Million - $8.9 Million	736,328 New	736,328 $7.86 Million
Q3 2023 Nov 14, 2023	SELL	$11.78 - $13.86 $39,745 - $46,763	-3,374 Reduced 1.52%	219,130 $2.66 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $2.39 Million - $2.96 Million	222,504 New	222,504 $2.79 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $1.84 Million - $2.36 Million	185,635 Added 176.63%	290,732 $3.55 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $852,621 - $1.11 Million	86,825 Added 475.18%	105,097 $1.1 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $113,834 - $203,184	18,272 New	18,272 $196,000
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $1.97 Million - $5.1 Million	-213,720 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $3.99 Million - $7.37 Million	-296,226 Reduced 58.09%	213,720 $4.94 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $166,255 - $204,949	-12,898 Reduced 2.47%	509,946 $7.2 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $2.56 Million - $4.53 Million	288,880 Added 123.47%	522,844 $7.88 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $372,168 - $626,455	-56,134 Reduced 19.35%	233,964 $2.16 Million
Q4 2019 Feb 18, 2020	BUY	$7.48 - $10.75 $152,599 - $219,310	20,401 Added 7.56%	290,098 $2.83 Million
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $173,745 - $287,048	-21,664 Reduced 7.44%	269,697 $2.16 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $1.71 Million - $2.25 Million	156,176 Added 115.53%	291,361 $3.64 Million
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $117,618 - $163,072	-11,715 Reduced 7.97%	135,185 $1.84 Million
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $602,404 - $966,147	-71,886 Reduced 32.86%	146,900 $1.41 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $2.09 Million - $2.98 Million	180,351 Added 469.24%	218,786 $2.65 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $3.14 Million - $4.09 Million	-239,243 Reduced 86.16%	38,435 $600,000
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $3.82 Million - $4.75 Million	277,678 New	277,678 $4.18 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$285 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$278 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$241 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$237 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$229 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.78B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account